LivaNova plc (LIVN): Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan

LivaNova PLC (LIVN) - logo korporat

LivaNova PLC enjoys global recognition for its development of neurostimulators and cardiac equipment, leveraging an expansion strategy for vagus nerve stimulation systems. Tracking the business's EV/EBITDA multiple history on GURU.Markets, we note that the 16.21 level reflects the current state of the parameter. High barriers to entry are sustained by FDA patents and the unwavering trust of surgeons in the brand's clinical outcomes.

LivaNova Group - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan LIVN (periode 23.11.2025 - 12.11.2026)
Produk sing diprodhuksi LivaNova

This ratio correlates the total enterprise value, including net debt, with operating profit before depreciation and amortization, allowing for an assessment of the asset's real value regardless of the tax burden. The current EV/EBITDA value for the heavy business segment stands at 16.21, which, combined with full capacity utilization at LivaNova PLC (LIVN) plants and the modernization of production lines, confirms the efficiency of cash flow generation despite high capital intensity.